Press Releases
Press Releases
National Coalition of Pharmaceutical Distributors Expert Addresses U.S. Senate Committee on Value of Small Distributors in Health Care
An industry analyst with the National Coalition of Pharmaceutical Distributors testified today to the U.S. Senate Committee on Commerce, Science & Transportation that small distributors are an important and necessary part of the health care supply chain. Patricia Earl,...
Press Releases
BioFocus Expands Its Drug Discovery Offering with Proteomics Technology from Activiomics
BioFocus and Activiomics today announced a strategic alliance which will allow BioFocus to offer Activiomics’ proteomics services to its customers, to improve identification of novel targets for drug discovery and biomarkers for diagnostics. Activiomics’ proprietary technology,...
Press Releases
Forest Laboratories and Almirall Announce FDA Approval of Tudorza™ Pressair™ for the Long-Term Maintenance Treatment of COPD
Forest Laboratories, Inc. and Almirall, S.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Tudorza™ Pressair™ for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and...
Press Releases
Secretary Sebelius announces innovative public-private partnerships to turn the tide together in fight against HIV/AIDS
In a speech at the opening session of the XIX International AIDS Conference (AIDS 2012), Health and Human Services (HHS) Secretary Kathleen Sebelius announced a series of innovative public-private partnerships in the fight against the HIV/AIDS epidemic. ...
Press Releases
Ligand Licensee Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis™ (carfilzomib) for Injection
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals , received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis™ (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple...
Press Releases
Pfizer and Northwestern University Win LYRICA® Patent Case in Delaware District Court
Pfizer Inc. announced today that the United States District Court for the District of Delaware upheld its composition of matter patent and pain and seizure use patents covering LYRICA® (pregabalin) capsules CV. With this decision, Pfizer will exclusively...
Press Releases
Novasep invests EUR three million to boost its HPAPI manufacturing capabilities
Novasep, a leading supplier of manufacturing solutions to the life sciences industries, today announces a EUR three million investment to expand its Highly Potent API (HPAPI) manufacturing capabilities at its facility in Le Mans, France. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read